Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

QILU

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 25
  • 0 comments

FDA approve ICOSAPENT ETHYL

Comment Full text

HERITAGE

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 25
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

KEY THERAP

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 28
  • 0 comments

FDA approve FENOPROFEN CALCIUM

Comment Full text

AVION PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 22
  • 0 comments

FDA approve MEFENAMIC ACID

Comment Full text

CHARTWELL MOLECULES

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 18
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

RISING

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 28
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

ZYLA LIFE SCIENCES

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 24
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

TWI PHARMS

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 24
  • 0 comments

FDA approve NAPROXEN SODIUM

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 24
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

ZYLA

  • FDA Approval
  • Nov. 22, 2024, 09:42 UTC
  • 20
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text
  • Previous
  • 214
  • 215
  • 216
  • 217
  • 218
  • Next

Search

News categories

  • Technical Exchange News(9910)
  • Event(410)
  • SEC News(167612)
  • FDA Approval(9356)
  • Company Report(721)
  • Business News(111521)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin